Evidence based evaluation of yihuohuatan Decoction in the treatment of stable chronic obstructive pulmonary disease
- Conditions
- Chronic obstructive pulmonary disease
- Registration Number
- ITMCTR2100005309
- Lead Sponsor
- ?????????
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
a. It conforms to the stable stage of COPD diagnosed by western medicine; b. It is consistent with the syndrome of qi deficiency, blood stasis and phlegm turbidity in traditional Chinese medicine; c. Between 40-80 years old; d. Sign informed consent.
a. Chronic cough and wheezing caused by tuberculosis, tumor, irritating gas allergy, asthma and other factors confirmed by examination; b. Complicated with serious primary diseases such as cardiovascular, liver, kidney and hematopoietic system; c. Chronic bronchitis complicated with severe cardiac insufficiency; d. Patients with abnormal behavior or mental illness; e. Allergic constitution; f. Failing to use drugs according to regulations, unable to judge the curative effect or incomplete data, which affects the judgment of curative effect or safety; g. Patients participating in other clinical trials
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method